Systemic Therapy for Advanced and Metastatic Colon Cancer
Colon cancer is one of the three most common cancers in both men and women in Organization for Economic Cooperation and Development countries. Approximately one-quarter of colon cancer patients have a metastasis at the time of diagnosis, and systemic therapy is used in many of them as a first line t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jin Publishing & Printing Co.
2019-04-01
|
| Series: | The Korean Journal of Gastroenterology |
| Subjects: | |
| Online Access: | http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2019.73.4.202 |
| id |
doaj-7f3b4fb3d5c04f03a6d7af494ef6b1e2 |
|---|---|
| record_format |
Article |
| spelling |
doaj-7f3b4fb3d5c04f03a6d7af494ef6b1e22020-11-25T00:33:32ZengJin Publishing & Printing Co.The Korean Journal of Gastroenterology1598-99922019-04-0173420220610.4166/kjg.2019.73.4.202kjg.2019.73.4.202Systemic Therapy for Advanced and Metastatic Colon CancerJae Jun Park0Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, KoreaColon cancer is one of the three most common cancers in both men and women in Organization for Economic Cooperation and Development countries. Approximately one-quarter of colon cancer patients have a metastasis at the time of diagnosis, and systemic therapy is used in many of them as a first line therapy. In addition to existing cytotoxic drugs, target therapy has been introduced in colon cancer and immunotherapy has shown clinical benefits in the treatment of metastatic colon cancer. The purpose of this review was to briefly summarize the National Comprehensive Cancer Network guidelines for systemic therapy in colon cancer with special reference to targeted agents and novel agents.http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2019.73.4.202Colon cancerAdvanced cancerMetastatic cancerSystemic therapy |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Jae Jun Park |
| spellingShingle |
Jae Jun Park Systemic Therapy for Advanced and Metastatic Colon Cancer The Korean Journal of Gastroenterology Colon cancer Advanced cancer Metastatic cancer Systemic therapy |
| author_facet |
Jae Jun Park |
| author_sort |
Jae Jun Park |
| title |
Systemic Therapy for Advanced and Metastatic Colon Cancer |
| title_short |
Systemic Therapy for Advanced and Metastatic Colon Cancer |
| title_full |
Systemic Therapy for Advanced and Metastatic Colon Cancer |
| title_fullStr |
Systemic Therapy for Advanced and Metastatic Colon Cancer |
| title_full_unstemmed |
Systemic Therapy for Advanced and Metastatic Colon Cancer |
| title_sort |
systemic therapy for advanced and metastatic colon cancer |
| publisher |
Jin Publishing & Printing Co. |
| series |
The Korean Journal of Gastroenterology |
| issn |
1598-9992 |
| publishDate |
2019-04-01 |
| description |
Colon cancer is one of the three most common cancers in both men and women in Organization for Economic Cooperation and Development countries. Approximately one-quarter of colon cancer patients have a metastasis at the time of diagnosis, and systemic therapy is used in many of them as a first line therapy. In addition to existing cytotoxic drugs, target therapy has been introduced in colon cancer and immunotherapy has shown clinical benefits in the treatment of metastatic colon cancer. The purpose of this review was to briefly summarize the National Comprehensive Cancer Network guidelines for systemic therapy in colon cancer with special reference to targeted agents and novel agents. |
| topic |
Colon cancer Advanced cancer Metastatic cancer Systemic therapy |
| url |
http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2019.73.4.202 |
| work_keys_str_mv |
AT jaejunpark systemictherapyforadvancedandmetastaticcoloncancer |
| _version_ |
1725316291045097472 |